Literature DB >> 11782650

The response of rabbit patellar tendons after autologous blood injection.

Mark A Taylor1, Timothy L Norman, Nina B Clovis, J David Blaha.   

Abstract

PURPOSE: Blood is a rich source of growth factors that can stimulate fibrocyte migration and help induce neovascular ingrowth. These properties may be able to stimulate a healing response in chronic degeneration of a tendon (tendonosis). The purpose of this study was to assess the biomechanical and histological effects of autologous blood injection on animal tendons.
METHODS: New Zealand white rabbit left side patellar tendons were injected with 0.15 cc of autologous blood. We then compared the mechanical properties and histology to the normal right patellar tendon at 6 and 12 wk.
RESULTS: At 6 and 12 wk after the injection, there were no differences in the histology compared with normal tendon tissue, and there were no significant changes in tendon stiffness. Biomechanically, the tendons were not damaged at 6 wk after the injection. By 12 wk, tendons that were injected with blood were significantly (P < 0.014) stronger.
CONCLUSION: We found that injecting blood directly into normal tendons appears safe. Further evaluation of this technique would appear indicated.

Entities:  

Mesh:

Year:  2002        PMID: 11782650     DOI: 10.1097/00005768-200201000-00012

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  12 in total

Review 1.  Ultrasound-guided intervention in the ankle and foot.

Authors:  Eleni E Drakonaki; Gina M Allen; Roland Watura
Journal:  Br J Radiol       Date:  2015-11-05       Impact factor: 3.039

Review 2.  Imaging of hamstring injuries: therapeutic implications.

Authors:  George Koulouris; David Connell
Journal:  Eur Radiol       Date:  2006-03-03       Impact factor: 5.315

3.  A retrospective comparison of the management of recalcitrant lateral elbow tendinosis: platelet-rich plasma injections versus surgery.

Authors:  Ronald D Ford; William P Schmitt; Kyle Lineberry; Paul Luce
Journal:  Hand (N Y)       Date:  2015-06

4.  Ultrasound guided dry needling and autologous blood injection for patellar tendinosis.

Authors:  Steven L J James; Kaline Ali; Chris Pocock; Claire Robertson; Joy Walter; Jonathan Bell; David Connell
Journal:  Br J Sports Med       Date:  2007-03-26       Impact factor: 13.800

Review 5.  Autologous blood and platelet-rich plasma injection therapy for lateral elbow pain.

Authors:  Teemu V Karjalainen; Michael Silagy; Edward O'Bryan; Renea V Johnston; Sheila Cyril; Rachelle Buchbinder
Journal:  Cochrane Database Syst Rev       Date:  2021-09-30

6.  Use of platelet-rich plasma for the treatment of refractory jumper's knee.

Authors:  Giuseppe Filardo; Elizaveta Kon; Stefano Della Villa; Ferruccio Vincentelli; Pier Maria Fornasari; Maurilio Marcacci
Journal:  Int Orthop       Date:  2009-07-31       Impact factor: 3.075

Review 7.  Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries.

Authors:  Kellie K Middleton; Victor Barro; Bart Muller; Satosha Terada; Freddie H Fu
Journal:  Iowa Orthop J       Date:  2012

8.  A randomised control trial to evaluate the efficacy of autologous blood injection versus local corticosteroid injection for treatment of lateral epicondylitis.

Authors:  C M Dojode
Journal:  Bone Joint Res       Date:  2012-08-01       Impact factor: 5.853

9.  Platelet rich plasma injection grafts for musculoskeletal injuries: a review.

Authors:  Steven Sampson; Michael Gerhardt; Bert Mandelbaum
Journal:  Curr Rev Musculoskelet Med       Date:  2008-12

10.  Effect of hyperbaric oxygen therapy combined with autologous platelet concentrate applied in rabbit fibula fraction healing.

Authors:  Paulo César Fagundes Neves; Simone de Campos Vieira Abib; Rogério Fagundes Neves; Oronzo Pircchio; Karen Ruggeri Saad; Paulo Fernandes Saad; Ricardo Santos Simões; Marcia Bento Moreira; Cristiano Frota de Souza Laurino
Journal:  Clinics (Sao Paulo)       Date:  2013-09       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.